Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Fulkerson

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
European Journal of Immunology|September 21, 2011
Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectorsRichard Hopkins, Anne Bridgeman, Charles Bourne, et al.
Journal of Virology|May 21, 2010
Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaquesMaximillian Rosario, John Fulkerson, Shamit Soneji, et al.
Osteoarthritis Imaging|July 16, 2026
Adverse Patellofemoral Morphology and Worsening Osteoarthritis: An Exploration of Composite vs. Single MRI OutcomesBrooke McGinley, Michael P LaValley, Johannes M Sieberer, et al.
Vaccines|September 8, 2015
Nonclinical Development of BCG Replacement Vaccine CandidatesKamalakannan Velmurugan, Leander Grode, Rosemary Chang, et al.
Journal of Virology|April 9, 2010
Novel recombinant Mycobacterium bovis BCG, ovine atadenovirus, and modified vaccinia virus Ankara vaccines combine to induce robust human immunodeficiency virus-specific CD4 and CD8 T-cell responses in rhesus macaquesMaximillian Rosario, Richard Hopkins, John Fulkerson, et al.
Vaccine|June 9, 2009
Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosisRonggai Sun, Yasir A W Skeiky, Angelo Izzo, et al.
Journal of Virology|January 22, 2010
Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 gag induces SIV-specific CD8+ T-cell responses in rhesus macaquesMyrna C Bonaldo, Mauricio A Martins, Richard Rudersdorf, et al.
Ebiomedicine|June 21, 2016
Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 TrialDaniel F Hoft, Azra Blazevic, Asmir Selimovic, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
European Journal of Immunology|September 21, 2011
Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectorsRichard Hopkins, Anne Bridgeman, Charles Bourne, et al.
Journal of Virology|May 21, 2010
Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaquesMaximillian Rosario, John Fulkerson, Shamit Soneji, et al.
Osteoarthritis Imaging|July 16, 2026
Adverse Patellofemoral Morphology and Worsening Osteoarthritis: An Exploration of Composite vs. Single MRI OutcomesBrooke McGinley, Michael P LaValley, Johannes M Sieberer, et al.
Vaccines|September 8, 2015
Nonclinical Development of BCG Replacement Vaccine CandidatesKamalakannan Velmurugan, Leander Grode, Rosemary Chang, et al.
Journal of Virology|April 9, 2010
Novel recombinant Mycobacterium bovis BCG, ovine atadenovirus, and modified vaccinia virus Ankara vaccines combine to induce robust human immunodeficiency virus-specific CD4 and CD8 T-cell responses in rhesus macaquesMaximillian Rosario, Richard Hopkins, John Fulkerson, et al.
Vaccine|June 9, 2009
Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosisRonggai Sun, Yasir A W Skeiky, Angelo Izzo, et al.
Journal of Virology|January 22, 2010
Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 gag induces SIV-specific CD8+ T-cell responses in rhesus macaquesMyrna C Bonaldo, Mauricio A Martins, Richard Rudersdorf, et al.
Ebiomedicine|June 21, 2016
Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 TrialDaniel F Hoft, Azra Blazevic, Asmir Selimovic, et al.
Pageof 2